• Je něco špatně v tomto záznamu ?

Influence of gemfibrozil on sulfate transport in human erythrocytes during the oxygenation-deoxygenation cycle

E. Tellone, S. Ficarra, R. Scatena, B. Giardina, A. Kotyk, A. Russo, D. Colucci, E. Bellocco, G. Lagana, A. Galtieri

. 2008 ; 57 (4) : 621-629.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10015632

The effects of gemfibrozil (GFZ), an antihyperlipidemic agent, on the anionic transport of the human red blood cells (RBC) during the oxygenation-deoxygenation cycle were examined. Gemfibrozil clearly plays a role in the modulation of the anionic flux in erythrocytes; in fact it causes a strong increment of anions transport when the RBCs are in the high-oxygenation state (HOS). Such an effect is remarkably reduced in the lowoxygenation state (LOS). With the aim of identifying the dynamics of fibrate action, this effect has been investigated also in human ghost and chicken erythrocytes. These latter, in fact, are known to possess a B3 (anion transporter or Band 3) modified at the cytoplasmic domain (cdb3) which plays a significant role in the metabolic modulation of red blood cells. The results were analyzed taking into account the well-known interactions between fibrates and both conformational states of hemoglobin i.e. the T state (deoxy-conformation) and the R state (oxy-conformation). The effect of gemfibrozil on anionic influx appears to be due to a wide interaction involving a “multimeric” Hb-GFZ-cdb3 macromolecular complex.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 50

000      
00000naa 2200000 a 4500
001      
bmc10015632
003      
CZ-PrNML
005      
20111210180536.0
008      
100718s2008 xr e eng||
009      
AR
024    7_
$a 10.33549/physiolres.931251 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Tellone, E.
245    10
$a Influence of gemfibrozil on sulfate transport in human erythrocytes during the oxygenation-deoxygenation cycle / $c E. Tellone, S. Ficarra, R. Scatena, B. Giardina, A. Kotyk, A. Russo, D. Colucci, E. Bellocco, G. Lagana, A. Galtieri
314    __
$a Department of Organic and Biological Chemistry, University of Messina, 98166 Messina, Italy
504    __
$a Lit.: 50
520    9_
$a The effects of gemfibrozil (GFZ), an antihyperlipidemic agent, on the anionic transport of the human red blood cells (RBC) during the oxygenation-deoxygenation cycle were examined. Gemfibrozil clearly plays a role in the modulation of the anionic flux in erythrocytes; in fact it causes a strong increment of anions transport when the RBCs are in the high-oxygenation state (HOS). Such an effect is remarkably reduced in the lowoxygenation state (LOS). With the aim of identifying the dynamics of fibrate action, this effect has been investigated also in human ghost and chicken erythrocytes. These latter, in fact, are known to possess a B3 (anion transporter or Band 3) modified at the cytoplasmic domain (cdb3) which plays a significant role in the metabolic modulation of red blood cells. The results were analyzed taking into account the well-known interactions between fibrates and both conformational states of hemoglobin i.e. the T state (deoxy-conformation) and the R state (oxy-conformation). The effect of gemfibrozil on anionic influx appears to be due to a wide interaction involving a “multimeric” Hb-GFZ-cdb3 macromolecular complex.
650    _2
$a financování organizované $7 D005381
650    _2
$a dospělí $7 D000328
650    _2
$a hypolipidemika $x farmakologie $7 D000960
650    _2
$a pufry $7 D002021
650    _2
$a kalibrace $7 D002138
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a erytrocytární membrána $7 D004910
650    _2
$a erytrocyty $x metabolismus $x účinky léků $7 D004912
650    _2
$a gemfibrozil $x farmakologie $7 D015248
650    _2
$a hemoglobiny $x metabolismus $7 D006454
650    _2
$a lidé $7 D006801
650    _2
$a indikátory a reagencie $7 D007202
650    _2
$a kinetika $7 D007700
650    _2
$a lidé středního věku $7 D008875
650    _2
$a spotřeba kyslíku $x fyziologie $x účinky léků $7 D010101
650    _2
$a proteinfosfatasy $x metabolismus $7 D010749
650    _2
$a konformace proteinů $7 D011487
650    _2
$a sírany $x krev $7 D013431
650    _2
$a vanadáty $x farmakologie $7 D014638
653    00
$a Sulfate transport
653    00
$a Oxygenation - deoxygenation
700    1_
$a Ficarra, S.
700    1_
$a Scatena, R.
700    1_
$a Giardina, B.
773    0_
$w MED00003824 $t Physiological research $g Roč. 57, č. 4 (2008), s. 621-629 $x 0862-8408
856    41
$u http://www.biomed.cas.cz/physiolres/pdf/57/57_621.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 8
990    __
$a 20100708110758 $b ABA008
991    __
$a 20100811121009 $b ABA008
999    __
$a ok $b bmc $g 756048 $s 619828
BAS    __
$a 3
BMC    __
$a 2008 $b 57 $c 4 $m Physiological research $x MED00003824 $d 621-629
LZP    __
$a 2010-32/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...